Peptonic Medical is a pharmaceutical company. Currently, the focus is on the treatment of female vaginal atrophy. The company offers a treatment free from oestrogen, where the products contain the oxytocin hormone. A large part of the projects is carried out in collaboration with other industry players. The main business is found on the Nordic market. The company is based in Bromma.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Maida Vale Capital AB | 15,65 | 15,65 | 2024-06-26 |
| Vidarstiftelsen | 11,05 | 11,05 | 2024-06-26 |
| Avanza Pension | 4,56 | 4,56 | 2024-06-26 |
| Heli Kurjanen | 3,71 | 3,71 | 2023-12-31 |
| Tarek Nabil Shoeb | 2,86 | 2,86 | 2024-06-26 |
| Stein Jens-Peter | 2,86 | 2,86 | 2024-06-26 |
| Mika Kurjanen | 1,93 | 1,93 | 2023-12-31 |
| Nordnet Pensionsförsäkring | 1,53 | 1,53 | 2024-06-26 |
| Quartier Latin AB | 1,37 | 1,37 | 2024-06-26 |
| Mgc Capital Limited | 1,21 | 1,21 | 2024-06-26 |
2024-08-13 Delårsrapport 2024-Q2
2024-11-06 Delårsrapport 2024-Q3
2025-02-21 Bokslutskommuniké 2024
